Ghent University Academic Bibliography

Advanced

Chlamydophila psittaci infections in turkeys: overview of economic and zoonotic importance and vaccine development

Kristel Verminnen UGent and Daisy Vanrompay UGent (2009) DRUGS OF TODAY. 45(suppl. B). p.147-150
abstract
We provide evidence on the multifactorial infectious etiology of respiratory disease in turkeys, Although Chlamydophila psittaci is difficult to diagnose, this entity should not be neglected in veterinary diagnostic laboratories. The present results suggest a pathogenic interplay between chlamydophila, avian metapneumovirus and Ornithobacterium rhinotracheale. Additionally, we demonstrate zoonotic transmission from turkeys to humans. Psittacosis due to contact with poultry probably occurs more often than is thought and the infection con be asymptomatic or symptomatic. There is no commercial C. psittaci vaccine available and currently the best option is an experimental major outer membrane protein-based DNA vaccine.
Please use this url to cite or link to this publication:
author
organization
year
type
journalArticle (original)
publication status
published
subject
keyword
CHALLENGE, PROTECTION, DNA VACCINATION, CHLAMYDIA-PSITTACI, OUTER-MEMBRANE PROTEIN
journal title
DRUGS OF TODAY
Drugs Today
volume
45
issue
suppl. B
pages
147 - 150
Web of Science type
Article
Web of Science id
000272015100021
JCR category
PHARMACOLOGY & PHARMACY
JCR impact factor
1.588 (2009)
JCR rank
162/236 (2009)
JCR quartile
3 (2009)
ISSN
1699-3993
language
English
UGent publication?
yes
classification
A1
id
806803
handle
http://hdl.handle.net/1854/LU-806803
date created
2009-12-10 18:03:56
date last changed
2017-05-22 11:36:21
@article{806803,
  abstract     = {We provide evidence on the multifactorial infectious etiology of respiratory disease in turkeys, Although Chlamydophila psittaci is difficult to diagnose, this entity should not be neglected in veterinary diagnostic laboratories. The present results suggest a pathogenic interplay between chlamydophila, avian metapneumovirus and Ornithobacterium rhinotracheale. Additionally, we demonstrate zoonotic transmission from turkeys to humans. Psittacosis due to contact with poultry probably occurs more often than is thought and the infection con be asymptomatic or symptomatic. There is no commercial C. psittaci vaccine available and currently the best option is an experimental major outer membrane protein-based DNA vaccine.},
  author       = {Verminnen, Kristel and Vanrompay, Daisy},
  issn         = {1699-3993},
  journal      = {DRUGS OF TODAY},
  keyword      = {CHALLENGE,PROTECTION,DNA VACCINATION,CHLAMYDIA-PSITTACI,OUTER-MEMBRANE PROTEIN},
  language     = {eng},
  number       = {suppl. B},
  pages        = {147--150},
  title        = {Chlamydophila psittaci infections in turkeys: overview of economic and zoonotic importance and vaccine development},
  volume       = {45},
  year         = {2009},
}

Chicago
Verminnen, Kristel, and Daisy Vanrompay. 2009. “Chlamydophila Psittaci Infections in Turkeys: Overview of Economic and Zoonotic Importance and Vaccine Development.” Drugs of Today 45 (suppl. B): 147–150.
APA
Verminnen, K., & Vanrompay, D. (2009). Chlamydophila psittaci infections in turkeys: overview of economic and zoonotic importance and vaccine development. DRUGS OF TODAY, 45(suppl. B), 147–150.
Vancouver
1.
Verminnen K, Vanrompay D. Chlamydophila psittaci infections in turkeys: overview of economic and zoonotic importance and vaccine development. DRUGS OF TODAY. 2009;45(suppl. B):147–50.
MLA
Verminnen, Kristel, and Daisy Vanrompay. “Chlamydophila Psittaci Infections in Turkeys: Overview of Economic and Zoonotic Importance and Vaccine Development.” DRUGS OF TODAY 45.suppl. B (2009): 147–150. Print.